|
Volumn 148, Issue 7, 2008, Pages 535-543
|
Screening for chronic obstructive pulmonary disease using spirometry: Summary of the evidence for the U.S. preventive services task force
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
FLUTICASONE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
INFLUENZA VACCINE;
IPRATROPIUM BROMIDE;
PLACEBO;
PNEUMOCOCCUS VACCINE;
SALBUTAMOL;
SALMETEROL;
TIOTROPIUM BROMIDE;
AGE DISTRIBUTION;
AIRWAY OBSTRUCTION;
BONE DENSITY;
CARDIOMYOPATHY;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DISEASE EXACERBATION;
DISEASE SEVERITY;
EVIDENCE BASED MEDICINE;
FALSE POSITIVE RESULT;
HEALTH STATUS;
HEART FAILURE;
HUMAN;
INJECTION SITE REACTION;
MALAISE;
MONOTHERAPY;
MYALGIA;
OROPHARYNX CANDIDIASIS;
OXYGEN THERAPY;
PNEUMONIA;
PRIORITY JOURNAL;
PULMONARY REHABILITATION;
REVIEW;
SCREENING TEST;
SIDE EFFECT;
SINUS TACHYCARDIA;
SKIN BRUISING;
SMOKING;
SMOKING CESSATION;
SPIROMETRY;
THROAT IRRITATION;
UNSTABLE ANGINA PECTORIS;
UPPER RESPIRATORY TRACT INFECTION;
URINARY TRACT INFECTION;
URINE RETENTION;
VACCINATION;
WHEEZING;
XEROSTOMIA;
ADULT;
IMMUNIZATION;
MASS SCREENING;
PREVALENCE;
RISK ASSESSMENT;
STATISTICS;
ADULT;
HUMANS;
IMMUNIZATION;
MASS SCREENING;
PREVALENCE;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
RISK ASSESSMENT;
SMOKING CESSATION;
SPIROMETRY;
|
EID: 42249096140
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-7-200804010-00213 Document Type: Review |
Times cited : (123)
|
References (36)
|